Access cutting-edge sexually transmitted disease (std) treatment through this clinical trial at a research site in Honolulu. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Honolulu location
Preparing your pre-screening questions…
Access sexually transmitted disease (std) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sexually transmitted disease (std) treatment provided free
Check if you qualify for this sexually transmitted disease (std) clinical trial in Honolulu, HI
No-Cost Study Care
Local to Honolulu
Convenient for HI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are: What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision? How does the uptake of such a service among patients receiving telemedicine abortion care compare to the population of patients who seek in-person medication abortion care? What are the positivity rates for STIs in among patients receiving telemedicine medication abortion care compared to the positivity rates for a contemporaneous, in-clinic population? What is the average time to between testing and treatment for patients who test positive for an STI using the self-collection service? Researchers will compare the intervention group to a contemporaneous, in-clinic population on uptake of STI screening, as well as on positivity rates for the STIs tested. Participants will be asked to perform self-swab collection for STI testing for gonorrhea, chlamydia, and trichomonas. They will be instructed to send their specimens to a lab using prepaid postage. Upon completion of sample collection and shipping, they will be asked to complete a survey assessing basic demographic information, as well as acceptability and feasibility of the intervention. Patients who test positive for an STI will be promptly provided/referred to treatment.
Sponsor: Queen's Medical Center
Yes, this clinical trial (NCT06951438) has an active research site in Honolulu, HI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for sexually transmitted disease (std) treatment options in Honolulu, HI, this clinical trial (NCT06951438) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Honolulu research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sexually transmitted disease (std) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all sexually transmitted disease (std) clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Honolulu — not just this study.
Browse Leukemia Trials in Honolulu →